Tetramisole in the treatment of nematode infections in man.
D000293:Adolescent; D000328:Adult; D000723:Ancylostomatoidea / Q000302:isolation & purification; D000871:Anthelmintics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001196:Ascariasis / Q000188:drug therapy; D001200:Ascaris / Q000302:isolation & purification; D001530:Belgium; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004757:Enterobius / Q000302:isolation & purification; D005243:Feces / Q000382:microbiology; D005260:Female; D006725:Hookworm Infections / Q000188:drug therapy; D006801:Humans; D007214:Indonesia; D008297:Male; D009349:Nematode Infections / Q000188:drug therapy* / Q000453:epidemiology; D010123:Oxyuriasis / Q000188:drug therapy; D010919:Placebos; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014257:Trichuriasis / Q000188:drug therapy; D014259:Trichuroidea / Q000302:isolation & purification
D000871:Anthelmintics; D010919:Placebos; D013844:Thiazoles